NO972764D0 - Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose - Google Patents

Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose

Info

Publication number
NO972764D0
NO972764D0 NO972764A NO972764A NO972764D0 NO 972764 D0 NO972764 D0 NO 972764D0 NO 972764 A NO972764 A NO 972764A NO 972764 A NO972764 A NO 972764A NO 972764 D0 NO972764 D0 NO 972764D0
Authority
NO
Norway
Prior art keywords
treatment
osteoarthritis
preparation
pharmaceutical compositions
strontium salts
Prior art date
Application number
NO972764A
Other languages
English (en)
Other versions
NO315840B1 (no
NO972764L (no
Inventor
Yannis Tsouderos
Pascale Deloffre
Michel Wierzbicki
Original Assignee
Adir
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adir filed Critical Adir
Publication of NO972764D0 publication Critical patent/NO972764D0/no
Publication of NO972764L publication Critical patent/NO972764L/no
Publication of NO315840B1 publication Critical patent/NO315840B1/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Inorganic Chemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Food Preservation Except Freezing, Refrigeration, And Drying (AREA)
  • Medicinal Preparation (AREA)
NO19972764A 1996-06-17 1997-06-16 Anvendelse av distrontiumsaltet av 2-[N,N- di(karboksymetyl)amino]-3-cyano-4-karboksymetyltiofen-5-karboksylsyre til fremstilling av etfarmasöytisk preparat for behandling av artrose NO315840B1 (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9607475A FR2749759B1 (fr) 1996-06-17 1996-06-17 Utilisation de sels de strontium pour l'obtention de compositions pharmaceutiques destinees au traitement de l'arthrose

Publications (3)

Publication Number Publication Date
NO972764D0 true NO972764D0 (no) 1997-06-16
NO972764L NO972764L (no) 1997-12-18
NO315840B1 NO315840B1 (no) 2003-11-03

Family

ID=9493102

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19972764A NO315840B1 (no) 1996-06-17 1997-06-16 Anvendelse av distrontiumsaltet av 2-[N,N- di(karboksymetyl)amino]-3-cyano-4-karboksymetyltiofen-5-karboksylsyre til fremstilling av etfarmasöytisk preparat for behandling av artrose

Country Status (16)

Country Link
US (1) US5856356A (no)
EP (1) EP0813869B1 (no)
JP (1) JP3935557B2 (no)
CN (1) CN1136856C (no)
AT (1) ATE233558T1 (no)
AU (1) AU711950B2 (no)
BR (1) BR9703603A (no)
CA (1) CA2206837C (no)
DE (1) DE69719408T2 (no)
DK (1) DK0813869T3 (no)
ES (1) ES2193337T3 (no)
FR (1) FR2749759B1 (no)
HU (1) HU227935B1 (no)
NO (1) NO315840B1 (no)
NZ (1) NZ328106A (no)
ZA (1) ZA975323B (no)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8303981B2 (en) 1996-08-27 2012-11-06 Baxter International Inc. Fragmented polymeric compositions and methods for their use
FR2828206B1 (fr) * 2001-08-03 2004-09-24 Centre Nat Rech Scient Utilisation d'inhibiteurs des lysyl oxydases pour la culture cellulaire et le genie tissulaire
NO20014746D0 (no) * 2001-09-28 2001-09-28 Clas M Kjoelberg Smertelindrende middel
FR2844797B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel des tetraesters de l'acide 5-[bis (carboxymethyl)]-3-carboxymethyl-4-cyano-2- thiophenecarboxylique, et application a la synthese des sels bivalents de l'acide ranelique et de leurs hydrates
FR2844795B1 (fr) * 2002-09-24 2004-10-22 Servier Lab Nouveau procede de synthese industriel du ranelate de strontium et de ses hydrates
FR2846558B1 (fr) * 2002-11-05 2006-07-14 Servier Lab Utilisation du sel distrontique de l'acide 2-n,n-di(carboxymethyl)amino-3-cyano-4-carboxymethyl- thiophene-5-carboxylique pour l'obtention de medicaments destines au traitement des douleurs gastro-duodenales
ES2553107T3 (es) * 2003-03-27 2015-12-04 Santosolve As Composición anti-inflamatoria basada en compuestos de estroncio
PT1622630E (pt) * 2003-05-07 2012-10-11 Osteologix As Combinações de estrôncio para a profilaxia/tratamento de patologias da cartilagem e/ou do osso
US20060216358A1 (en) * 2003-05-07 2006-09-28 Christian Hansen Controlled release composition containing a strontium salt
PT1534305E (pt) * 2003-05-07 2007-02-28 Osteologix As Tratamento de afecções cartilagineas / osseas com sais de estroncio hidrosoluveis
US7927626B2 (en) 2003-08-07 2011-04-19 Ethicon, Inc. Process of making flowable hemostatic compositions and devices containing such compositions
US20080167513A1 (en) * 2004-02-26 2008-07-10 Osteologlx A/S Strontium-Containing Compounds for Use in the Prevention or Treatment of Necrotic Bone Conditions
JP4954867B2 (ja) * 2004-05-06 2012-06-20 オステオロジックス エイ／エス 有機金属塩類を製造するための高収率で迅速な合成法
EP1758652A2 (en) * 2004-06-17 2007-03-07 Osteologix A/S Improving pain treatment with strontium combinations
JP2008502609A (ja) * 2004-06-17 2008-01-31 オステオロジックス エイ／エス リウマチおよび関節性疾患の治療改善方法
US7618651B2 (en) * 2004-06-24 2009-11-17 Idexx Laboratories Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
DK1768748T4 (da) * 2004-06-25 2019-06-11 Mokwalo Spf S A Sammensætninger omfattende strontium og vitamin D og anvendelser deraf
CN101018586B (zh) * 2004-06-25 2014-08-27 莫克瓦洛Spf有限公司 含锶和维生素d的组合物及其用途
FR2875807B1 (fr) * 2004-09-30 2006-11-17 Servier Lab Forme cristalline alpha du ranelate de strontium, son procede de preparation, et les compositions pharmaceutiques qui la contiennent
SI1799196T1 (sl) 2004-10-08 2016-10-28 Forward Pharma A/S Farmacevtski sestavki z nadzorovanim sproščanjem, obsegajoči ester fumarne kisline
US20080004344A1 (en) * 2004-11-10 2008-01-03 Aditech Pharma Ab Novel Salts of Fumaric Acid Monoalkylesters and Their Pharmaceutical Use
EP1855654A1 (en) * 2005-02-28 2007-11-21 Osteologix A/S Tablets comprising a high load of strontium
FR2899895B1 (fr) 2006-04-12 2010-09-17 Servier Lab Nouveaux sels de strontium d'acides sulfoniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
PL2029184T3 (pl) * 2006-05-26 2011-08-31 Baxter Int Wstrzykiwalna kompozycja do augmentacji kości
GB0612028D0 (en) * 2006-06-16 2006-07-26 Imp Innovations Ltd Bioactive glass
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
CN101204375B (zh) * 2006-12-19 2010-09-29 北京德众万全药物技术开发有限公司 一种雷奈酸锶干混悬剂
ES2573327T3 (es) * 2007-04-23 2016-06-07 Baxter International Inc. Composiciones de fibrina que contienen compuestos de estroncio
GB0713094D0 (en) * 2007-07-05 2007-08-15 Imp Innovations Ltd Glass polycarboxylate cements
GB0724556D0 (en) * 2007-12-17 2008-01-30 Queen Mary & Westfield College LAtency associated protein construct with aggrecanase sensitive cleavage site
CN102014973A (zh) 2008-02-29 2011-04-13 弗罗桑医疗设备公司 用于促进止血和/或伤口愈合的装置
CA2725253A1 (en) * 2008-05-27 2009-12-03 Imperial Innovations Limited Process for producing porous scaffolds from sinterable glass
GB0809592D0 (en) * 2008-05-27 2008-07-02 Imp Innovations Ltd Biomaterials
EP2564839B1 (en) 2009-01-09 2016-05-11 Forward Pharma A/S Pharmaceutical formulation comprising one or more fumaric acid esters in an erosion matrix
GB0911365D0 (en) 2009-06-30 2009-08-12 Bioceramic Therapeutics Ltd Multicomponent glasses for use as coatings and in personal care products
FR2953139B1 (fr) 2009-11-27 2012-04-13 Servier Lab Composition pharmaceutique comprenant un sel de strontium, de la vitamine d et une cyclodextrine
WO2011110597A1 (de) 2010-03-11 2011-09-15 Azad Pharmaceutical Ingredients Ag Verfahren zur herstellung von strontiumranelat
SA111320355B1 (ar) 2010-04-07 2015-01-08 Baxter Heathcare S A إسفنجة لايقاف النزف
AU2011260260B2 (en) 2010-06-01 2015-09-03 Baxter Healthcare S.A. Process for making dry and stable hemostatic compositions
EP2530068A1 (en) 2011-05-31 2012-12-05 Lacer, S.A. New strontium salts, synthesis and use thereof in the treatment of osteoporosis
ES2938568T3 (es) 2011-10-11 2023-04-12 Baxter Int Composiciones hemostaticas
HK1201212A1 (en) 2011-10-11 2015-08-28 Baxter International Inc Hemostatic compositions
SG11201401878SA (en) 2011-10-27 2014-09-26 Baxter Int Hemostatic compositions
WO2013131520A2 (en) 2012-03-06 2013-09-12 Ferrosan Medical Devices A/S Pressurized container containing haemostatic paste
RU2636240C2 (ru) 2012-06-12 2017-11-21 Ферросан Медикал Дивайсиз А/С Сухая гемостатическая композиция
EP3010419B1 (en) 2013-06-21 2020-05-20 Ferrosan Medical Devices A/S Vacuum expanded dry composition and syringe for retaining same
JP6489485B2 (ja) 2013-12-11 2019-03-27 フェロサン メディカル デバイシーズ エイ／エス 押し出し増強因子を含んでいる乾燥組成物
CA2960309A1 (en) 2014-10-13 2016-04-21 Ferrosan Medical Devices A/S Dry composition for use in haemostasis and wound healing
RU2705905C2 (ru) 2014-12-24 2019-11-12 Ферросан Медикал Дивайсиз А/С Шприц для удерживания и смешивания первого и второго веществ
AU2016290433B2 (en) 2015-07-03 2018-05-24 Ferrosan Medical Devices A/S Syringe for mixing two components and for retaining a vacuum in a storage condition
WO2018084959A2 (en) 2016-09-30 2018-05-11 Nelson Deanna J Pharmaceutical quality strontium l-lactate
ES2968412T3 (es) 2018-05-09 2024-05-09 Ferrosan Medical Devices As Método para preparar una composición hemostática

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4152431A (en) * 1977-09-22 1979-05-01 William H. Rorer, Inc. Compositions and method of use
FR2633619B1 (fr) * 1988-06-29 1991-02-08 Adir Nouveau sel de strontium, son procede de preparation et les compositions pharmaceutiques le renfermant
FR2651497B1 (fr) * 1989-09-01 1991-10-25 Adir Nouveaux sels de metaux bivalents de l'acide n, n-di (carboxymethyl)amino-2 cyano-3 carboxymethyl-4 carboxy-5 thiophene, leur procede de preparation et les compositions pharmaceutiques les renfermant.

Also Published As

Publication number Publication date
HU9701059D0 (en) 1997-08-28
AU2490297A (en) 1998-01-08
DE69719408D1 (de) 2003-04-10
HU227935B1 (en) 2012-06-28
CA2206837C (fr) 2002-12-03
CN1179944A (zh) 1998-04-29
NO315840B1 (no) 2003-11-03
JPH1059852A (ja) 1998-03-03
ATE233558T1 (de) 2003-03-15
NZ328106A (en) 2001-04-27
DK0813869T3 (da) 2003-06-02
NO972764L (no) 1997-12-18
CA2206837A1 (fr) 1997-12-17
DE69719408T2 (de) 2003-12-24
HUP9701059A3 (en) 1998-05-28
JP3935557B2 (ja) 2007-06-27
EP0813869B1 (fr) 2003-03-05
US5856356A (en) 1999-01-05
EP0813869A1 (fr) 1997-12-29
CN1136856C (zh) 2004-02-04
FR2749759B1 (fr) 1999-11-26
HUP9701059A2 (hu) 1998-03-02
ES2193337T3 (es) 2003-11-01
FR2749759A1 (fr) 1997-12-19
ZA975323B (en) 1998-01-14
BR9703603A (pt) 1998-09-01
AU711950B2 (en) 1999-10-28

Similar Documents

Publication Publication Date Title
NO972764L (no) Anvendelse av strontiumsalter for fremstilling av farmasöytiske sammensetninger for behandling av artrose
SE9604786D0 (sv) New compounds
UA26213C2 (uk) Засіб для профілактики та лікуваhhя остеопорозу та фармацевтичhа композиція hа їх осhові
IE862554L (en) Pharmaceutical compositions
IL101243A0 (en) Pharmaceutical compositions for treatment of benign prostatic hyperplasia
IL81887A0 (en) Dihydroisoxazole derivatives,their preparation and pharmaceutical compositions containing them
PL323825A1 (en) Peptidyloheterocycli compounds useful in treating diorders associated with thrombosin
DE69332732D1 (de) Pharmazeutische Zusammensetzung und Methode zur Behandlung von Hyperlipidämie und Arterioskerose
NO20016198D0 (no) Orale farmasöytiske sammensetninger som inneholder taxaner og fremgangsmåter for anvendelse av samme i behandling
NO914352L (no) Fremgangsmaate for behandling av brukte katodebunner
ZA948669B (en) New pyrazine carboxamide derivatives the preparation thereof and their use in pharmaceutical compositions
GB8900678D0 (en) Compositions for the prevention and medical treatment of parodonthopathy
IL101574A0 (en) Combination pharmaceutical compositions for the treatment of benign prostatic hyperplasia
DE68913739D1 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
DE69512929D1 (de) Salze von aminoalkoholen und diese enthaltende pharmazeutische zusammensetzungen
KR880700673A (ko) 골손상 치료용방법 및 조성물
AU1430492A (en) Pharmaceutical composition for the treatment of gastritis
DE69405919D1 (de) Zusammensetzungen zur Behandlung von Keratinfasern
DE69420229D1 (de) Pharmazeutische Zusammensetzung zur Behandlung von AIDS
IL97054A0 (en) Pharmaceutical compositions comprising buspirones for the treatment of sleep apneas
FI852730A0 (fi) (pyrrol-1-yl) -fenyl-dihydropyridazinoner, deras framstaellning och anvaendning.
HU9700642D0 (en) Use of bradiquinine antagonists for producing pharmaceutical compositions for treating fibrogenetic and acut hepatopathias
HUP9903679A3 (en) Use of olanzapine for the preparation of pharmaceutical compositions treating bipolar disorder
DE69009211D1 (de) Derivate von Thiazolidin-4-carbonsäure, deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
AU3992897A (en) Use of sulbutiamine to obtain pharmaceutical compositions useful in the treatment of certain psychomotor and psycho-intellectual disorders

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees